Holen Sie sich die Stockscreener-App
1.19
0.85%
0.01
Schlusskurs vom Vortag:
$1.18
Offen:
$1.2
24-Stunden-Volumen:
12,040
Relative Volume:
0.16
Marktkapitalisierung:
$20.46M
Einnahmen:
$48.43M
Nettoeinkommen (Verlust:
$-11.04M
KGV:
-1.7761
EPS:
-0.67
Netto-Cashflow:
$-7.00M
1W Leistung:
+4.39%
1M Leistung:
+26.56%
6M Leistung:
+25.26%
1J Leistung:
-33.89%
1-Tages-Spanne:
$1.19
$1.20
1-Wochen-Bereich:
$1.13
$1.2291
52-Wochen-Spanne:
$0.782
$1.80
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Vergleichen Sie IRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.19 | 20.28M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
126.98 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.58 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.94 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.41 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.49 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
IRIDEX Corp: Can This Beaten-Down Ophthalmic Stock Still See The Light? - AD HOC NEWS
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World
IRIX SEC FilingsIridex 10-K, 10-Q, 8-K Forms - Stock Titan
Is IRIDEX Corporation stock a top momentum playJuly 2025 Macro Moves & Daily Stock Momentum Reports - Улправда
Published on: 2025-12-19 17:58:41 - Улправда
What margin trends mean for IRIDEX Corporation stockJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - Улправда
[Form 4] IRIDEX CORP Insider Trading Activity - Stock Titan
Why retail investors pile into IRIDEX Corporation stockRisk Management & High Conviction Investment Ideas - Улправда
IRIDEX (IRIX) director William Moore reports 20,000-share stock purchase - Stock Titan
Iridex CFO Dizon buys $2296 in company stock By Investing.com - Investing.com Nigeria
I’ve reviewed the SEC filing and prepared the following news article - Investing.com UK
Dir Moore Buys 30,000 ($28.5K) Of IRIDEX Corp [IRIX] - TradingView — Track All Markets
Iridex CFO Dizon buys $2296 in company stock - Investing.com
IRIDEX Corporation (NASDAQ: IRIX) presents at Sidoti Year-End Virtual Investor Conference - Stock Titan
Iridex study shows MicroPulse laser retreatment effective for glaucoma - Investing.com
Iridex study shows MicroPulse laser retreatment effective for glaucoma By Investing.com - Investing.com Canada
Iridex Corporation Announces Positive Findings on MicroPulse Technology for Glaucoma Retreatment in Independent Study - Quiver Quantitative
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management - The Manila Times
Iridex (IRIX) Reveals Study on Laser Treatments for Glaucoma - GuruFocus
Iridex Corporation Announces Publication of Study on Thermal Dynamics of Laser Treatments for Glaucoma - Quiver Quantitative
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment - marketscreener.com
Iridex (NASDAQ: IRIX) publishes thermal modeling study on MicroPulse vs CW glaucoma lasers - Stock Titan
Iridex (Nasdaq: IRIX) sets Dec. 11 slot at Sidoti virtual investor conference - Stock Titan
Is IRIDEX Corporation stock vulnerable to regulatory risksJuly 2025 Action & AI Enhanced Trading Signals - Newser
Iridex (IRIX) Stock Analysis Report | Financials & Insights - Benzinga
Iridex CFO Dizon buys $5529 in company stock By Investing.com - Investing.com Australia
Iridex CFO Dizon buys $5529 in company stock - Investing.com India
Iridex CFO Dizon buys $960 in company stock By Investing.com - Investing.com South Africa
Iridex CFO Dizon buys $960 in company stock - Investing.com
Will IRIDEX Corporation stock keep outperforming rivals2025 Key Highlights & Safe Entry Zone Tips - newser.com
Iridex CFO Dizon buys $2k in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Dizon buys $2k in company stock - Investing.com
How IRIDEX Corporation stock reacts to global recession fears2025 Buyback Activity & Weekly Return Optimization Alerts - newser.com
Why IRIDEX Corporation stock is a must watch in 2025Weekly Market Outlook & Low Volatility Stock Recommendations - newser.com
Iridex director Moore buys shares worth $48,331 By Investing.com - Investing.com Australia
Iridex CFO Dizon buys shares worth $2998 By Investing.com - Investing.com Nigeria
Iridex director Moore buys shares worth $48,331 - Investing.com India
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iridex Corp-Aktie (IRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Dec 12 '25 |
Buy |
0.97 |
2,365 |
2,296 |
92,685 |
| Dizon Romeo R | Chief Financial Officer |
Dec 02 '25 |
Buy |
0.95 |
1,584 |
1,498 |
90,320 |
| Dizon Romeo R | Chief Financial Officer |
Nov 20 '25 |
Buy |
0.96 |
5,760 |
5,530 |
88,736 |
| Dizon Romeo R | Chief Financial Officer |
Nov 19 '25 |
Buy |
0.96 |
1,000 |
960 |
82,976 |
| Dizon Romeo R | Chief Financial Officer |
Nov 18 '25 |
Buy |
0.94 |
2,133 |
2,005 |
81,976 |
| MOORE WILLIAM M | Director |
Nov 14 '25 |
Buy |
0.97 |
28,157 |
27,245 |
228,831 |
| MOORE WILLIAM M | Director |
Nov 17 '25 |
Buy |
0.97 |
21,843 |
21,087 |
250,674 |
| Dizon Romeo R | Chief Financial Officer |
Nov 17 '25 |
Buy |
0.96 |
3,124 |
2,999 |
79,843 |
| Dizon Romeo R | Chief Financial Officer |
Nov 14 '25 |
Buy |
0.88 |
14,769 |
12,997 |
76,719 |
| Dizon Romeo R | Chief Financial Officer |
Sep 12 '25 |
Buy |
1.36 |
1,450 |
1,975 |
61,950 |
1.20%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):